Call for Abstract

3rd International Conference on Clinical Pharmacy, will be organized around the theme “Development in Clinical Pharmacy to Meet Emerging Challenges”

Clinical Pharmacy 2015 is comprised of 19 tracks and 122 sessions designed to offer comprehensive sessions that address current issues in Clinical Pharmacy 2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Symposium on

Clinical Research in Osteopathic Manuel Therapy: “Differences and equalities to research in Clinical Pharmacy”

By

Dr. Stig Larsen

Prof. Controlled Clinical Research Methodology and Statistics

Norwegian University of Life Sciences

 

 

  • Track 1-1BP-C1 in treatment of Metastatic Breast Cancer; A randomised, double blinded and placebo controlled clinical study.
  • Track 1-2A new anti-cancer substance normalizing the blood picture in patients suffering from metastatic breast cancer stage IV
  • Track 1-3The effect of Osteopathic Manipulation Therapy (OMT) in patients suffering from Gastroesophageal Reflux Disease (GERD)
  • Track 1-4Osteopathic treatment of patients suffering from chronic non-specific low back pain: A dose- response pilot study
  • Track 1-5Dose-response study in Osteopathic treatment of patients suffering from foot related pain
  • Track 1-6Reliability and Validity of an eye tracking technology
  • Track 2-1The principles of individualization of drug therapy
  • Track 2-2Bio-Pharmaceutics
  • Track 2-3Drug interactions and adverse drug reactions
  • Track 2-4Therapeutic drug monitoring
  • Track 2-5Pharmacotherapy and outcome research
  • Track 2-6Pharmacoepidemiology
  • Track 2-7Pharmacodynamics and pharmacokinetics
  • Track 2-8Pharmacogenetics and pharmacogenomics
  • Track 3-1Communication barriers in counseling foreign-language patients
  • Track 3-2Improving patient care in the rural communities
  • Track 3-3The role of clinical pharmacist to improve medication administration
  • Track 3-4Off-label and unlicensed drug usage
  • Track 3-5Medical controversies
  • Track 3-6The legal and practical aspects of prescribing
  • Track 3-7Role of pharmacist in communicating and counseling patients
  • Track 3-8Implementation of clinical pharmacy service
  • Track 4-1Public health challenges and the role of community pharmacy
  • Track 4-2Treatment approaches to cure diabetes
  • Track 4-3Ischemic heart disease and congestive heart failure
  • Track 4-4Alzheimer’s disease
  • Track 4-5Emergency medicine pharmacy practice
  • Track 4-6Optimizing strategies for administration of drugs in pediatrics
  • Track 4-7Cardiology and oncology
  • Track 4-8Parkinson’s disease
  • Track 4-9New oral and intravenous anticancer treatments
  • Track 4-10Update on renal therapeutics
  • Track 4-11Clinical Pharmacy Management
  • Track 5-1Dispensing precaution: Safety of prescriptions
  • Track 5-2Dispensing multiple repeat prescriptions at one time
  • Track 5-3Extemporaneous dispensing (compounding)
  • Track 5-4Labeling of dispensed medicines
  • Track 5-5Counseling patients about prescribed medicines
  • Track 5-6Dispensing errors and near misses
  • Track 5-7The role of pharmacists in interpreting the result
  • Track 6-1Clinical trials and drug information
  • Track 6-2Outcome research and pharmacoeconomic studies
  • Track 6-3Clinical case studies
  • Track 6-4Role of pharmacist in communicating and counseling patients
  • Track 6-5Clinical genomics and proteomics
  • Track 6-6Risks and benefits of drug therapy
  • Track 6-7Preparation of personalized formulation
  • Track 6-8Therapeutic drug monitoring
  • Track 6-9Influence of national and formulating policies in drug development
  • Track 6-10Pharmacy Clinical Services
  • Track 7-1Poison control system and drug research unit
  • Track 7-2Infectious disease management program
  • Track 7-3Program for pharmaceutical economics and policy studies (ProPEPS)
  • Track 7-4Satellite pharmacy education programs
  • Track 7-5Translational and policy research on personalized medicine
  • Track 7-6Medication management service
  • Track 8-1Genomics Guiding Therapeutic Decisions
  • Track 8-2Rational therapeutics
  • Track 8-3Evidence-based practice
  • Track 8-4Safety, cost-effectiveness and clinical efficacy of drugs
  • Track 8-5Drug interactions
  • Track 8-6Clinical impact of drug formulations
  • Track 8-7Personalized, stratified and translational medicine
  • Track 8-8Developing of novel medication safety clinical programs
  • Track 8-9Clinical Drug Development
  • Track 9-1Safety of prescriptions
  • Track 9-2Drug delivery systems
  • Track 9-3Drug formulation development
  • Track 9-4Rationale in prescribing drugs
  • Track 9-5Drug toxicity mechanism
  • Track 9-6Study of drug dependency
  • Track 9-7Toxicogenomics
  • Track 10-1Drug discovery and development
  • Track 10-2Technologies in drug delivery systems
  • Track 10-3Drug metabolism in modern drug discovery
  • Track 10-4Vaccines against drug abuse
  • Track 10-5Global Clinical Development
  • Track 11-1Analysis of fluid dispensing problems
  • Track 11-2High performance fluid dispensing modeling
  • Track 11-3Other clinical aspects of pharmacy
  • Track 11-4Clinical use of medicines, medical devices and laboratory tests
  • Track 12-1Approaches to pain management
  • Track 12-2Central nerve blocks & peripheral nerve blocks
  • Track 12-3Research ethics including genome studies and placebo research
  • Track 12-4Obstacles to optimal care
  • Track 12-5Functional neuroimaging of pain
  • Track 12-6Non-pharmacological pain management
  • Track 12-7Interventional pain management
  • Track 12-8Chronic musculoskeletal pain including fibromyalgia and osteoarthritis
  • Track 12-9Headache & low back pain
  • Track 12-10Basic science research & translational pain research
  • Track 12-11Chronic and postoperative pain management
  • Track 13-1Common mental health conditions in children and adolescents
  • Track 13-2Psychiatric disorders, peptic ulcer disease and infectious diseases
  • Track 13-3Child development, cognitive psychology
  • Track 13-4Personality, memory and the social psychology
  • Track 14-1Antimicrobial resistance and preventing infection
  • Track 14-2Cost effectiveness of drugs for the treatment of disorders
  • Track 14-3Influencing prescribing in primary care: A collaboration between clinical pharmacology and clinical pharmacy
  • Track 14-4Clinical pharmacists in emergency medicine
  • Track 14-5Clinical Pharmacy for medicine management
  • Track 15-1Applying technology to patient care
  • Track 15-2Improving care to chronic conditions
  • Track 15-3Compatibility between patient safety and health care technology
  • Track 15-4Diagnostics and Biomedical Technologies
  • Track 16-1Molecular pharmacology
  • Track 16-2Molecular pharmacokinetics
  • Track 16-3Molecular pharmaco-biology
  • Track 16-4Molecular pharmaceutics & organic process research
  • Track 17-1Clinical immunology of major diseases
  • Track 17-2Autoimmune diseases
  • Track 17-3Allergy and immunology
  • Track 17-4HIV/AIDS
  • Track 17-5Immunomodulation and immunotherapy
  • Track 18-1Drug absorption and Routes of administration
  • Track 18-2Effects of Disease on Drug Disposition
  • Track 18-3Introduction of New Drugs and Clinical Trials
  • Track 18-4Clinical Immunopharmacology
  • Track 19-1Clinical Pharmacy In Usa
  • Track 19-2Clinical Pharmacy In Europe
  • Track 19-3Clinical Pharmacy In Asia
  • Track 19-4Clinical Pharmacy In Middile East